President & CEO at Immunome, a Biotechnology Company focused on developing novel cancer and infectious disease therapies based on harnessing human immune response. Over 25+ years of experience in building value across various segments of the pharmaceutical and biomedical industries. Most recently, built TARIS Biomedical into a high value therapeutic oncology company as its first President &CEO. Raised $107 M in equity financing and sold company's lead program LiRIS for the treatment of Interstitial Cystitis to Allergan in a deal worth up to $588M in August 2014. Ex-General Manager of Drug Delivery Business at Cephalon (managed 300+ employees) and over 10+ years at Nektar Therapeutics (managed 150+ employees) in various capacities in General Management, Product Development, Research, Program Management and Corporate Development & Strategy. Over 5+ years in product development at SmithKline Beecham.Specialties: Building Products and Companies, Corporate Strategy, M&A, Business Development, Venture Financing, Pharmaceutical R&D, Product Development, Drug-Device Combinations, General Manager, Chief Executive Officer